About: science-based policy

Health 09-02-2017

Commission must take action against endocrine disruptors

Reducing exposure to endocrine disrupting chemicals will benefit healthcare systems and economies as a whole, writes Christian Zahn.

Trade & Society 13-09-2016

A plea for science-based standards in TTIP

The EU’s preference for the “precautionary principle” over science-based decision-making is a barrier to transatlantic trade in the meat industry. TTIP and regulatory convergence would benefit both EU and US farmers, argues Barry Carpenter.

[epSos.de/Flickr]

What does an innovation agenda mean for consumers?

Innovation and consumer protection are not opposites. Indeed there is huge potential to use innovation to deliver safer products that benefit consumers, writes Monique Goyens.

Chemicals

The EU’s confused evidence processes for identifying endocrine disruptors

A group of scientists has written to the European Commission to voice concerns about burden of proof and confused evidence requirements to identify and classify endocrine disruptors under the PPP and Biocides Regulations.

Chemicals ‘fitness check’ should improve EU legislation, not water it down

The scope of the European Commission’s Fitness Check on chemicals is limited to a comparison of the “hazard versus risk” approaches in chemicals legislation. This is misguided, writes Dolores Romano, who argues a hazard-based approach can help protect people and the environment while supporting innovation.

Democracy denied: How the Commission keeps people out of lawmaking

With its Better Regulation agenda, the European Commission talks big about making EU decisions more transparent and increasing public participation. But the reality is very different, writes Anaïs Berthier.

 VideoSponsored

Endocrine disruption: the view of the chemical industry

Endocrine disruption is an important issue of significant public, political and scientific interest. Even though it can give rise to a very emotional debate, policymakers and authorities should deal with endocrine disruptive substances, as with all chemical substances, via a science- and risk-based regulation. Whether a chemical substance can and will cause harm is a fundamental distinction for both authorities and industry in order to effectively protect people and the environment.

Hans-Olaf Henkel from the Alternative for Germany (AfD) party

SOS for science-based EU policy-making

The past few months have not been a triumph for science-based policy making in the EU, writes Hans-Olaf Henkel.

‘Suppressed’ EU report could have banned pesticides worth billions

As many as 31 pesticides with a value running into billions of pounds could have been banned because of potential health risks, if a blocked EU paper on hormone-mimicking chemicals had been acted upon, the Guardian has learned.

Juncker still mulling scientific advice role after Glover’s position axed

The function of Chief Scientific Adviser to the European Commission "has ceased to exist", Anne Glover confirmed yesterday (13 November) but that does not mean the position will not be re-established by the new Commission President Jean-Claude Juncker, EURACTIV understands.

[Photo: Shutterstock]

When science meets politics: the EU’s impact assessment review

The European Commission is reviewing its impact assessment guidelines amid accusations that science is becoming increasingly politicised and scientists manipulated by policymakers and powerful interest groups.

Anne Glover at the 20th European Biomass Conference and Exhibition, 18-22 June 2012 [Photo: European Biomass Conference and Exhibition / Flickr]

Glover: EU chief scientist should stay in the shadows

Anne Glover, the EU’s Chief Scientific Advisor, has said that her opinions to the European Commission should remain independent from politics and therefore “not transparent” and immune from public scrutiny. The incoming Commission chief, Jean-Claude Juncker, is considering to maintain her position after Barroso leaves, EURACTIV understands.

Anne Glover speaking at the Friends of Europe - EU 2050: Europe's Tech Revolution (Photo: Flickr: OB-Pic 043)

EU twisting facts to fit political agenda, chief scientist says

A big challenge for the next European Commission will be to disconnect its evidence gathering processes from the “political imperative” that’s driving policy proposals, according to Anne Glover, the EU’s chief scientific advisor.

When politics trumps science: The curious case of the EU’s GMO authorisation system

Policy makers generally trust the scientific recommendations of independent EU agencies. But in the GMO area, a vicious circle of lack of approvals and decreased trust in the technology is being perpetuated, leading to a negative precedent of “politics over science”, writes Nathalie Moll.

 VideoSponsored

European Risk Summit 2013

The European Risk Summit, hosted in June 2013, has brought renewed focus to the issue of evidence and risk-based rulemaking, and has highlighted the critical role that science plays in policy formation at EU level.

Top EU scientist calls for ethical standards to ease suspicion of industry

The suspicion that industrial involvement in science is only geared towards profit threatens to derail European policymaking and new ethical standards could help solve the issue, the EU’s chief scientific advisor has said.

Climate change 04-03-2013

EEA chief: ‘Scientific uncertainty is not a justification for inaction’

Use of the Precautionary Principle in EU decision-making has been criticised by some business groups but it must remain a central plank in responsible policy process, argues Jacqueline McGlade, the executive director of the European Environment Agency.